Entity Details

Primary name SC5A6_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9Y289
EntryNameSC5A6_HUMAN
FullNameSodium-dependent multivitamin transporter
TaxID9606
Evidenceevidence at protein level
Length635
SequenceStatuscomplete
DateCreated2001-01-24
DateModified2021-06-02

Ontological Relatives

GenesSLC5A6

GO terms

Show/Hide Table
GOName
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0006768 biotin metabolic process
GO:0006814 sodium ion transport
GO:0008523 sodium-dependent multivitamin transmembrane transporter activity
GO:0009925 basal plasma membrane
GO:0012506 vesicle membrane
GO:0015225 biotin transmembrane transporter activity
GO:0015233 pantothenate transmembrane transporter activity
GO:0015293 symporter activity
GO:0015878 biotin transport
GO:0015887 pantothenate transmembrane transport
GO:0015939 pantothenate metabolic process
GO:0016020 membrane
GO:0016323 basolateral plasma membrane
GO:0016324 apical plasma membrane
GO:0031526 brush border membrane
GO:0055085 transmembrane transport
GO:0090482 vitamin transmembrane transporter activity
GO:0150104 transport across blood-brain barrier
GO:1904200 iodide transmembrane transport
GO:1905135 biotin import across plasma membrane

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001734 Sodium/solute symporterFamilyFamily
IPR018212 Sodium/solute symporter, conserved siteSiteConserved site
IPR038377 Sodium/glucose symporter superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618973 OMIMNeurodegeneration, infantile-onset, biotin-responsive (NERIB)An autosomal recessive disorder characterized by early infantile onset, progressive neurodegeneration, global developmental delay, and developmental regression with loss of early motor and cognitive milestones. Additional variable features include seizures, ataxia, spasticity, peripheral neuropathy, immune defects, and osteopenia. Treatment with biotin, pantothenic acid, and lipoate may result in clinical improvement. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00121 BiotinDrugbanksmall molecule
DB00166 Lipoic acidDrugbanksmall molecule
DB08872 Gabapentin enacarbilDrugbanksmall molecule

Interactions

5 interactions